Skip to search formSkip to main contentSkip to account menu

Systemic Lupus Erythematosus Disease Activity Index

Known as: SLEDAI 
A clinical index for the measurement of disease activity in systemic lupus erythematosus. The index utilizes 24 weighted variables that measure… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Decoy receptor 3 (DcR3/TR6) is a decoy receptor for the Fas ligand (FasL) and can inhibit FasL‐induced apoptosis. It has been… 
Highly Cited
2007
Highly Cited
2007
OBJECTIVES Toll-like receptor 9 (TLR9) is a pattern-associated receptor functioning in innate immunity that may be involved in… 
Highly Cited
2002
Highly Cited
2002
OBJECTIVE To determine the urinary levels of soluble vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion… 
2001
2001
OBJECTIVE To examine the correlation between C-reactive protein (CRP) and CRP-inducing cytokines (IL-1 beta, IL-6, TNF-alpha) and… 
Highly Cited
2000
Highly Cited
2000
OBJECTIVE To determine whether vaccination of patients with systemic lupus erythematosus (SLE) with influenza virus vaccine is… 
Highly Cited
1999
Highly Cited
1999
OBJECTIVE Most information available about the disease course of patients with systemic lupus erythematosus (SLE) is restricted… 
Highly Cited
1998
Highly Cited
1998
Our objective was to determine the effect of 1 year low-dose cyclosporine A (CSA) treatment on disease activity and renal… 
1998
1998
OBJECTIVE To perform an exploratory analysis of the relative contribution of single MHC genes to the pathogenesis of systemic… 
Highly Cited
1995
Highly Cited
1995
Complement activation products (CAP) have been reported as sensitive markers of disease activity in systemic lupus erythematosus…